Key result
Among patients with diabetes undergoing percutaneous coronary intervention, a high comorbidity burden (CCI ≥3) significantly increased the risk of non-ischemic heart disease-related readmission within one year (OR 3.6).
Why the study?
To investigate the incidence, causes, and probability of re-hospitalization within 30 and 365 days after PCI in patients with diabetes.
What are the rates and predictors of re-hospitalization within 30 and 365 days after PCI in patients with diabetes?
Cohort (n=2,673)
Yes
What are the rates and predictors of re-hospitalization within 30 and 365 days after PCI in patients with diabetes?
Odds Ratio: 3.6 (95% CI 2.8–4.6)
p-value: p=<0.0001
More than half of patients with diabetes undergoing PCI are readmitted within 1 year, with non-cardiac reasons strongly predicted by baseline comorbidities.
No takes yet. Share an insight, caveat, or question.
High readmission rates after PCI in diabetes warrant closer post-discharge monitoring; leaves open effective preventive strategies.
Hansen et al. (2022) conducted a cohort in Diabetes mellitus and coronary artery disease requiring percutaneous coronary intervention (n=2,673). High comorbidity burden (CCI ≥3) vs. No comorbidities (CCI 0) was evaluated on Non-ischemic heart disease-related readmission within 365 days (OR 3.6, 95% CI 2.8-4.6, p=<0.0001). Among patients with diabetes undergoing percutaneous coronary intervention, a high comorbidity burden (CCI ≥3) significantly increased the risk of non-ischemic heart disease-related readmission within one year (OR 3.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: